Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo
The development of monoclonal antibodies to treat disease caused by filoviruses, particularly Ebola virus, has risen steeply in recent years thanks to several key studies demonstrating their remarkable therapeutic potential. The increased drive to develop new and better monoclonal antibodies has nec...
Saved in:
Main Authors: | Logan Banadyga (Author), Zachary Schiffman (Author), Shihua He (Author), Xiangguo Qiu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
by: Pengfei Fan, et al.
Published: (2020) -
Filovirus-reactive antibodies in humans and bats in Northeast India imply zoonotic spillover.
by: Pilot Dovih, et al.
Published: (2019) -
Undiscovered Bat Hosts of Filoviruses.
by: Barbara A Han, et al.
Published: (2016) -
Emerging Challenges in Filovirus Infections
Published: (2020) -
Correction: Filovirus-reactive antibodies in humans and bats in Northeast India imply zoonotic spillover.
by: Pilot Dovih, et al.
Published: (2021)